Cargando…
Visceral leishmaniasis: Experimental models for drug discovery
Visceral leishmaniasis (VL) or kala-azar is a chronic protozoan infection in humans associated with significant global morbidity and mortality. The causative agent is a haemoflagellate protozoan Leishmania donovani, an obligate intracellular parasite that resides and multiplies within macrophages of...
Autores principales: | Gupta, Suman, Nishi |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3100143/ https://www.ncbi.nlm.nih.gov/pubmed/21321417 |
Ejemplares similares
-
A chronic bioluminescent model of experimental visceral leishmaniasis for accelerating drug discovery
por: Álvarez-Velilla, Raquel, et al.
Publicado: (2019) -
Drug Resistance in Visceral Leishmaniasis
por: Maltezou, Helena C.
Publicado: (2010) -
Epidemiology of visceral leishmaniasis
por: Ready, Paul D
Publicado: (2014) -
The dynamics of granuloma formation in experimental visceral leishmaniasis
Publicado: (1988) -
Hemophagocytosis in Experimental Visceral Leishmaniasis by Leishmania donovani
por: Morimoto, Ayako, et al.
Publicado: (2016)